A Placebo Controlled, Double Blind, Randomised, 8-week Phase IIa Proof of Concept Study to Assess the Efficacy and Safety of AKR 202 in Patients With Osteoarthritis Pain
Clinical trial NCT02003118 · COMPLETED
Trial details
- NCT number
- NCT02003118
- Sponsor
- Akron Molecules AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-07-01
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.